To determine whether LI-LARP1 is expressed in a wider panel of cancer cell lines, we investigated the expression levels of LI-LARP1 and SI-LARP1 across the NCI-60 cancer cell panel [16] containing a selection of melanoma, renal, ovarian, brain, leukaemia, breast, non-small cell lung and prostate cancer cell lines (Fig. 3C). Here, LARP1 is linked to prostate carcinoma.